| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10220216 | Gynecologic Oncology | 2018 | 7 Pages |
Abstract
Although the primary endpoint was not met, IFRT might be safe and effective for in-field tumor control in patients with persistent epithelial ovarian cancer with a limited number of metastatic foci. We plan to conduct a larger scale multi-center phase II prospective study.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Jee Suk Chang, Sang Wun Kim, Yeon-Joo Kim, Joo-Young Kim, Sang-Yoon Park, Jin Hee Kim, Tae-Kyu Jang, Yong Bae Kim,